Management of High Iron with Normal Ferritin
When serum iron or transferrin saturation is elevated (≥45%) but ferritin remains normal, this pattern suggests early iron overload that requires genetic testing for hereditary hemochromatosis, as the combination of elevated transferrin saturation with any ferritin level warrants HFE genotyping. 1, 2
Initial Diagnostic Workup
Measure fasting transferrin saturation alongside serum ferritin to properly evaluate iron status, as these two parameters together distinguish true iron overload from secondary causes. 1, 2
Key laboratory tests to order immediately include:
- Fasting transferrin saturation (morning sample preferred) to confirm elevation ≥45% 1, 2
- Complete metabolic panel including ALT, AST to assess for occult liver disease 2, 3
- Complete blood count to evaluate for underlying hematologic disorders 3
- HFE genetic testing for C282Y and H63D mutations if TS ≥45% 1, 2, 4
Understanding This Pattern
This presentation represents a critical early detection window for hereditary hemochromatosis before significant iron accumulation occurs. 1, 5
The elevated transferrin saturation indicates:
- Increased circulating iron available for tissue deposition 1, 5
- Hepcidin deficiency allowing excessive iron absorption 1
- Early-stage iron overload before storage sites are saturated 5, 6
Normal ferritin in this context does NOT exclude iron overload—it simply indicates iron stores have not yet accumulated to elevated levels. 5, 6
Genetic Testing Algorithm
If TS ≥45% with normal ferritin, proceed immediately to HFE genotype testing for C282Y and H63D mutations without waiting for ferritin to rise. 1, 2, 4
Interpretation of genetic results:
- C282Y homozygotes: Confirms HFE hemochromatosis; initiate therapeutic phlebotomy even with normal ferritin if TS ≥45% 1, 2, 4
- C282Y/H63D compound heterozygotes: May cause iron overload, especially with additional risk factors (alcohol, NAFLD, viral hepatitis) 1, 3
- H63D homozygotes or single mutations: Unlikely to cause significant iron overload alone; evaluate for secondary causes 1, 3
- Negative HFE testing: Consider non-HFE hemochromatosis (TFR2, SLC40A1, HAMP, HJV mutations) or secondary causes 1, 3, 7
Management Based on Genotype
For Confirmed HFE Hemochromatosis (C282Y Homozygotes)
Initiate therapeutic phlebotomy immediately even with normal ferritin, as elevated TS indicates active iron loading. 1, 2, 4
Phlebotomy protocol:
- Remove 500 mL blood weekly or biweekly initially 2
- Check hemoglobin/hematocrit before each phlebotomy; postpone if anemia develops 1, 2
- Monitor ferritin every 10-12 phlebotomies initially, then more frequently as it approaches target 1, 2
- Target ferritin 50-100 μg/L for maintenance therapy 1, 2
- Allow hemoglobin to fall no more than 20% from baseline 2
No liver biopsy is needed in patients <40 years with normal liver enzymes, no hepatomegaly, and ferritin <1000 μg/L. 1, 2, 4
Maintenance Therapy
Once target ferritin is achieved:
- Continue maintenance phlebotomy every 2-4 months (typically 3-6 times yearly) to maintain ferritin 50-100 μg/L 1, 4
- Monitor ferritin every 3 months once stable 1, 2
- Alternative approach: Cease phlebotomy with close monitoring, reinstituting when ferritin reaches upper limit of normal 1
Family Screening
Screen all first-degree relatives with serum ferritin, transferrin saturation, and HFE genetic testing if hemochromatosis is confirmed. 1, 2, 4
Siblings have a 25% chance of being C282Y homozygotes if the proband has hereditary hemochromatosis. 4
Lifestyle Modifications
Avoid iron-containing vitamin supplements and iron-fortified foods (breakfast cereals). 1
Limit alcohol consumption to below thresholds for alcohol-related liver disease, as alcohol downregulates hepcidin and increases iron absorption. 1
Avoid raw or undercooked seafood, particularly in warm coastal waters, due to risk of severe Vibrio vulnificus infection in patients with iron overload. 1
Limit vitamin C supplements to ≤500 mg/day, as high doses may increase iron absorption and potentially cause cardiac toxicity. 1
Monitoring for Complications
Even with normal ferritin, establish baseline assessment for:
- Liver disease: Ultrasound if hepatomegaly or elevated transaminases 1, 2
- Diabetes screening: Fasting glucose or HbA1c 1
- Arthropathy assessment: Joint examination, particularly metacarpophalangeal joints 1
- Cardiac evaluation: ECG if severe iron overload suspected 2
Critical Pitfalls to Avoid
Never dismiss elevated transferrin saturation simply because ferritin is normal—this represents early-stage iron overload requiring intervention. 5, 6
Do not wait for ferritin to rise before initiating genetic testing when TS ≥45%, as this delays diagnosis and allows progressive iron accumulation. 1, 2
Never use ferritin alone without transferrin saturation to evaluate iron status, as this misses early iron overload. 2, 3
Do not fail to screen first-degree relatives if HFE-related hemochromatosis is confirmed, as penetrance is higher in family members. 1, 2, 4
Special Considerations
If genetic testing is negative but TS remains ≥45%:
- Evaluate for secondary causes: Chronic hematologic disorders (thalassemia, myelodysplastic syndrome, sickle cell disease), chronic liver disease, excessive iron intake 7, 8, 6
- Consider hepatic MRI to quantify liver iron concentration if clinical suspicion remains high 2, 3, 7
- Reassess in 3-6 months with repeat iron studies, as some patients show fluctuating values 8, 6
In patients taking proton pump inhibitors, reduced iron absorption may mask the severity of iron loading; consider this when interpreting iron parameters. 1